Free Trial

Nicholson Wealth Management Group LLC Buys 9,311 Shares of Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Nicholson Wealth Management Group LLC boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 141.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,906 shares of the company's stock after acquiring an additional 9,311 shares during the period. Nicholson Wealth Management Group LLC's holdings in Colgate-Palmolive were worth $1,446,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the fourth quarter worth about $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $43,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

CL traded up $1.69 during trading on Friday, hitting $89.56. The stock had a trading volume of 4,747,229 shares, compared to its average volume of 4,453,167. The firm has a market cap of $72.68 billion, a PE ratio of 25.44, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $84.45 and a 12 month high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a 50 day simple moving average of $88.94 and a 200-day simple moving average of $95.91.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm posted $0.87 EPS. Analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive's payout ratio is 56.82%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CL shares. Raymond James reaffirmed an "outperform" rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reiterated a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $101.16.

Get Our Latest Stock Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines